FDA Revokes Avastin's Breast Cancer Indication
FDA Revokes Avastin's Breast Cancer Indication
DG Alert: The commissioner for the US Food and Drug Administration announced today she will revoke the breast cancer indication for Avastin (bevacizumab), citing "it is clear that women who take Avastin for metastatic breast cancer risk potentially life-threatening side effects" without proof of a benefit that would justify those risks.
Janette
[phpBB Debug] PHP Warning: in file [ROOT]/vendor/twig/twig/lib/Twig/Extension/Core.php on line 1266: count(): Parameter must be an array or an object that implements Countable
Return to “Secondary Breast Cancer”
Who is online
Users browsing this forum: No registered users and 17 guests